References
- . Package Insert for Suboxone Sublingual Film. Richmond, VA: Reckitt Benckiser, 2014
- . Fareed A, Vayalapalli S, Casarella J, Drexler K. Effect of Buprenorphine dose on treatment outcome. J Addictive Dis. 2012;31(1):8–18
- . Greenwald M, Johanson C, Moody D, . Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers. Neuropscyhopharmacology. 2003;28(11):2000–2009
- . National Institute of Drug Abuse. Understanding Drug Abuse and Addiction: What Science Says. 2007. http://www.drugabuse.gov/publications/teaching-packets/understanding-drug-abuse-addiction/section-iv/6-cost-effectiveness-drug-treatment. Accessed July 2014
- . Clay E, Khemiri A, Zah V, Ruby J, Asche C. Persistence and healthcare utilization associated with the use of buprenorphine/naloxone film and tablet formulation therapy in adults with opioid dependence [published online ahead of print June 6, 2014]. J Med Econ. doi:10.3111/136969 98.2014.925463
- . Kharitonova E, Clay E, Ruby J, Aballea S, Zah V. Retrospective study of persistence and healthcare charges among opioid-dependent patients treated with buprenorphine/naloxone film and tablet formulations using a privately insured retrospective database. Paper presented at the 25th Annual Academy of Managed Care Pharmacy Meeting and Expo, April 3–6, 2013, San Diego, CA
- . Kharitonova E, Clay E, Ruby J, Aballea S, Zah V. Retrospective study of persistence and healthcare charges among opioid-dependent patients treated with buprenorphine/naloxone film and tablet formulations using a privately insured retrospective database. Paper presented at the 44th Annual Medical Scientific Conference of American Society of Addiction Medicine, April 25–28, 2013, Chicago, IL
- . Optum insight. Clinformatics Data Mart. 2014. http://www.optumin-sight.com/life-sciences/solutions/value-strategy/marketing-analytics/clinformatics-data-mart/∼/media/Ingenix/Life_Sciences/Documents/OptumInsightLifeSciencesClinformaticsDataMart_old.pdf. Accessed July 2014
- . National Center for Health Statistics (NCHS) and the Centers for Medicare and Medicaid Services. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). 2013. http://www.cdc.gov/nchs/icd/icd9cm.htm. Accessed July 2014
- . Baser O, Chalk M, Fiellin DA, Gastfriend DR. Cost and utilization outcomes of opioid-dependence treatments. Am J Manag Care. 2011;17( Suppl 8):S235–S248